Overall, this study comprehensively elucidated the prognostic MDEGs landscape, established novel prognostic MPMs using large-scale PRAD transcriptome data, and identified MIOX as a potential prognostic target in PRAD patients from multiple cohorts. The gene discussed is MIOX; the disease is prostate adenocarcinoma.